Internal Medicine, Endocrinology, Diabetes, & Metabolism · Manati, PR
NPI
1639101926
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Doctor's Center Hospital, Carr 2 Km 47.7
Manati, PR, 00674
Phone (787) 690-0096
Medicare paid, 2024
$17K
302 services
Medicare patients, 2024
87
Average age 74
Drug cost, 2024
$3.8M
13,577 prescriptions
Company payments, 2025
$3,227
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramon Ortiz Carrasquillo was code 93000 (electrocardiogram), 83 times for 59 patients. In total Ramon Ortiz Carrasquillo billed 302 services in 9 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 83 | 59 | $9.94 | $825 |
| 99213 Office E&M - Established | Office | 77 | 44 | $58.04 | $4,469 |
| 99214 Office E&M - Established | Office | 70 | 42 | $90.39 | $6,328 |
By year: 2022 $19K for 346 services; 2023 $19K for 327 services; 2024 $17K for 302 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramon Ortiz Carrasquillo prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,774 prescriptions and refills. In total Ramon Ortiz Carrasquillo wrote 13,577 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,774 | 4,467 | 535 | $198K |
| Ozempic Semaglutide | 889 | 971 | 167 | $919K |
| Metformin Hcl Generic | 762 | 1,876 | 260 | $5,840 |
| Rosuvastatin Calcium Generic | 631 | 1,654 | 246 | $8,862 |
| Atorvastatin Calcium Generic | 521 | 1,428 | 203 | $7,159 |
| Glimepiride Generic | 452 | 1,028 | 142 | $7,469 |
| Trulicity Dulaglutide | 452 | 576 | 86 | $574K |
| Ezetimibe Generic | 447 | 1,170 | 178 | $10K |
| Mounjaro Tirzepatide | 422 | 435 | 65 | $469K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 349 | 533 | 100 | $49K |
| Losartan Potassium Generic | 311 | 844 | 127 | $4,757 |
| Amlodipine Besylate Generic | 304 | 823 | 116 | $1,925 |
| Levothyroxine Sodium Generic | 293 | 741 | 91 | $4,559 |
| Gabapentin Generic | 227 | 597 | 107 | $3,173 |
| Humalog Insulin Lispro | 222 | 329 | 57 | $37K |
Brand drugs: 6,242 claims; generic drugs: 6,751 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramon Ortiz Carrasquillo $3,227 ($3,227 in general payments such as food, travel and fees) from 7 companies. The largest payer was Eli Lilly and Company with $2,994.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.